Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an <scp>AVA</scp> ® <scp>e‐Device</scp> in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients-Reference-Cited by-同舟云学术

Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA ® e‐Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients

Published:2022-12 Issue:12 Volume:47 Page:2345-2349
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Borrás‐Blasco Joaquin¹^ORCID,Vicente‐Escrig Esther²,Rodríguez‐Lucena Francisco José³,García‐Monsalve Ana⁴,Arroyo‐Domingo Elena³,Ferrando‐Piqueres Raul²,Casterá Elvira¹,Navarro‐Ruiz Andrés⁴

Affiliation:

1. Pharmacy Service Hospital de Sagunto Sagunto Spain

2. Pharmacy Service Hospital General Universitario de Castellón Castellón Spain

3. Pharmacy Service Hospital Vega Baja Orihuela Spain

4. Pharmacy Service Hospital General Universitario de Elche Elche Spain

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13820

Reference12 articles.